SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-21-034591
Filing Date
2021-03-11
Accepted
2021-03-10 18:16:35
Documents
5
Period of Report
2021-03-10

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm219179d1_6k.htm 6-K 14733
2 EXHIBIT 23.1 tm219179d1_ex23-1.htm EX-23.1 2322
3 EXHIBIT 99.1 tm219179d1_ex99-1.htm EX-99.1 474247
4 EXHIBIT 99.2 tm219179d1_ex99-2.htm EX-99.2 384051
5 EXHIBIT 99.3 tm219179d1_ex99-3.htm EX-99.3 260047
  Complete submission text file 0001104659-21-034591.txt   1136407
Mailing Address SMEDELAND 36 2600 GLOSTRUP COPENHAGEN G7 00000
Business Address SMEDELAND 36 2600 GLOSTRUP COPENHAGEN G7 00000 4588773600
Zealand Pharma A/S (Filer) CIK: 0001674988 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38178 | Film No.: 21731141
SIC: 2834 Pharmaceutical Preparations